Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Should Cover Dual-Eligibles, Merck Says; Industry Applauds Bill

Executive Summary

Merck wants dual-eligible seniors to be covered by the new Medicare Rx benefit to ensure that they are protected by formulary practice standards included in the bill
Advertisement

Related Content

Medicare Rx Card: Will Drug Discounts Be Permanent Program Fixture?
Merck Looks Past Medicare: Next Up, Covering The Uninsured
Pfizer Medicare Message: “Safeguards” Critical, Rx Growth Will Follow
Formularies Would Be Authorized But Restricted Under Senate Medicare Bill
Lilly Rallies The Troops: Price Controls Would Trigger “Death Spiral”
Lilly U.K. Evista Ads With Breast Cancer Claim Are Misleading - PMCPA
Lilly U.K. Evista Ads With Breast Cancer Claim Are Misleading - PMCPA
Pharmachemie Cisplatin ANDA Should Get 180-Day Exclusivity As First To File
Advertisement
UsernamePublicRestriction

Register

PS042054

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel